当前位置: X-MOL 学术JAMA Cardiol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Early-Onset Atrial Fibrillation and Heritable Heart Disease—To Test or Not to Test?
JAMA Cardiology ( IF 24.0 ) Pub Date : 2021-09-08 , DOI: 10.1001/jamacardio.2021.3367
Gordon F Tomaselli 1 , Megan J Roy-Puckelwartz 2
Affiliation  

Atrial fibrillation (AF) is the most common sustained arrhythmia in humans, with an estimated 5.2 million patients in 2010 and a projection of more than 12 million being affected by 2030.1 The incidence and risk are progressive with age, with a cumulative risk of less than 5% in individuals younger than 55 years, with a lifetime risk of 37% influenced by clinical and genetic factors.2 This arrhythmia is a major source of morbidity and mortality worldwide, with a number of clinical risk factors, including hypertension, obesity, diabetes, sleep apnea, and myocardial, valvular, and arrhythmogenic heart diseases.



中文翻译:

早发性房颤和遗传性心脏病——检测还是不检测?

心房颤动 (AF) 是人类最常见的持续性心律失常,2010 年估计有 520 万患者,预计到 2030将有超过 1200 万人受到影响。1发病率和风险随着年龄的增长而增加,累积风险为在 55 岁以下的个体中低于 5%,受临床和遗传因素影响的终生风险为 37%。2这种心律失常是全世界发病率和死亡率的主要来源,具有许多临床危险因素,包括高血压、肥胖、糖尿病、睡眠呼吸暂停以及心肌、瓣膜和心律失常性心脏病。

更新日期:2021-09-08
down
wechat
bug